End-stage renal disease in China

Kidney International

Volumn 49, Issue 1, 1996, Pages 287-301

  Li, Leishi ^a,b  

^a NANJING UNIVERSITY   (China)

^b JINLING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CASE REPORT; CHRONIC KIDNEY FAILURE; HERBAL MEDICINE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MALE; PRIORITY JOURNAL; REVIEW; RHUBARB;

EID: 0030045685     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.41     Document Type: Article

References (81)

1. LI LS, LIU ZH, YU YS: Mesangial IgA nephropathy: a clinical view. Chin J Nephrol 8:106-109, 1992
2. LI L, LI LS, CHEN HP, ZHOU HZ, JI DX, TANG Z, YU YS, BAI XY, ZHOU H: Primary glomerulonephritis in China. Chin Med J 102:159-164, 1989
3. LI LS: An overview of nephrology in China. Chin Med J 102:488-498, 1989
4. US RENAL DATA SYSTEM: USRDS 1990 Annual Data Report. Causes of ESRD. Am J Kidney Dis 16 (suppl 2):22-27, 1990
5. MANI MK: Chronic renal failure in India. Nephrol Dial Transplant 8:684-689, 1993
6. CASSIDY MJD, KERR DNS: The assessment of the patient with chronic renal insufficiency, in Oxford Textbook of Nephrology (1st ed, vol 2), edited by CAMERON S, Oxford Medical, New York, 1992, p 1157
7. LIU KD: Demography of renal transplantation therapy in China. Chin J Organ Transplant 6:112, 1985
8. MDRD STUDY GROUP (PREPARED BY KOPPLE JD, CHUMLEA WC, GASSMAN JS, HOLLINGER DL, MARONEY BJ, MERRILL D, SCHERCH LK, SCHULMAN G, ZIMMER GS): Relationship between GFR and nutritional status-Results from the MDRD study (abstract). J Am Soc Nephrol 5: 335, 1994
9. KLAHR S, LEVEY AS, BECK GJ, CAGGINLA AW, HUNSICKER L, KUSEK JW, STRIKER G: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330:929-930, 1994
10. AURELL M: ACE inhibition: antihypertensive treatment of choice in progressive chronic renal failure? Nephrol Dial Transplant 8:680-681, 1993
11. KLAHR S: Low-protein diets and angiotensin-converting enzyme inhibition in progressive renal failure. Am J Kidney Dis 22:114-119, 1993
12. LEWIS EJ, HUNSICKER LG, BAIN RP, ROHDE RD: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
13. RODICIO JL: Clinical experience in the treatment of non-diabetic renal disease: Summary and concluding remarks. Kidney Int (suppl)45: S179-S180, 1994
14. TER WEE PM, DONKER AB JM: Clinical strategies for arresting progression of renal disease. Kidney Int 42 (suppl 38):S114-S120, 1994
15. LI LS, LIU ZH, ZHANG JH, YAO J, YANG JW, ZHEN F: Experimental and clinical study of rheum officinale on prevention of chronic renal failure. Chin J Integr Trad West Med 11:392-396, 1991
16. CHEN QH, YU WH, LAI WS: Studies on Chinese rhubarb: III, Determination of anthraquinone derivatives in body fluids and tissues. Acta Pharm Sinica 10:455-459, 1963
17. CHEN OH, KAO SM, DU HF, YU WH: Studies on Chinese rhubarb: IV, Absorption, distribution and excretion of anthraquinone derivatives. Acta Pharm Sinica 10:525-530, 1963
18. ZHENG JH: HPLC determination of 34 chemical constituents in three officinale rhubarbs. J Beijing Med Univ 21:54-55, 1989
19. +-ATPase of rabbit renal medulla and their diuretic action. Acta Pharm Sinica 23:17-20, 1988
20. CHE CL, CHEN QH: Biochemical study of Chinese Rhubarb. XIX. Localization of inhibition of anthraquinone derivatives on the mitochondrial respiratory chain. Acta Pharm Sinica 22:12-18, 1987
21. YOKOZAWA T: Effects of rhubarb tannins on uremic toxins. Nephron 58:155-160, 1991
22. MITSUMA T, TERASAWA K, YOKOZAWA T, OURA H: Rhubarb therapy in patients with chronic renal failure (Part 1). J Med Pharm Soc WAKAN-YAKU 1:266-278, 1984
23. YOKOZAWA T, SUZUKI N, OKUDA I, OURA H, NISHIOKA I: Uremia-preventive effect of rhubarb extract in rats. Med Pharm Soc WAKAN-YAKU 2:344-350, 1985
24. MITSUMA T, YOKOZAWA T, OUKA H, TERASAWA K: Rhubarb therapy in patients with chronic renal failure (Part 2). Jpn J Nephrol 29:195-207, 1987
25. YOKOZAWA T, SUZUKI N, OURA H, NONAKA GI, NISHIOKA I: Effect of extracts obtained from rhubarb in rats with chronic renal failure. Chem Pharm Bull (Tokyo) 34:4718-4723, 1986
26. YOKOZAWA T, SUZUKI N, OKUDA I, OURA H, NISHIOKA I: Changes in the urinary constituents in rats with chronic renal failure during oral administration of rhubarb extract. Chem Pharm Bull (Tokyo) 33: 4508-4514, 1985
27. YOKOZAWA T, SUZUKI N, ZHENG PD, OURA H, NISHIOKA I: Effect of orally administered rhubarb extract in rats with chronic renal failure. Chem Pharm Bull (Tokyo) 32:4506-4513, 1984
28. WANG SR, CHEN OH: Studies on Chinese rhubarb: XIII. Interaction of anthraquinone derivatives of Chinese rhubarb with DNA. Acta Biochim Biophys Sinica 9:95-98, 1977
29. SUN Y, CHEN OH: Isolation and identification of emodin metabolites in mice and rats in vitro and in vivo. Acta Biochim Biophys Sinica 19:447-453, 1987
30. CAI YN, CHEN QH: Biochemical study of Chinese Rhubarb XXVIII. Comparison of biological activities of the metabolites of anthraquinone derivatives in animal body. J China Pharma Univ 19:282-284, 1988
31. SUN Y, LI W, CHEN OH: Effects of anthraquinone derivatives on cytochrome P-450 in mice liver microsomes. J China Pharm Univ 19:110-112, 1988
32. LU M, CHEN QH: Biochemical study of Chinese Rhubarb XXX. Immunosuppressive effects of anthraquinone derivatives. J China Pharm Univ 20:223-226, 1989
33. ZHENG F, LI LS: Effect of rheum officinale on the proliferation of renal tubular cells in vitro. Natl Med China 73:343-345, 1993
34. HU WX, LI LS, ZHANG YY: The effect of LDL and emodin on the growth of cultured rat mesangial cells. Bull Jinling Hosp 6:60-63, 1993
35. YAO J, LI LS, ZHAO R: Suppressive effect of rheum officinale on the proliferation of renal mesangial cells in vitro. Bull Jinling Hosp 73:343-345, 1993
36. LIU ZH, LI LS, HU WX, ZHOU H: Effect of Emodin on c-myc proto-oncogene expression in mesangial cells. J Nephrol Dial Transplant 1:27-30, 1992
37. LIU ZH, HU WX, LI LS, ZHOU H: Effect of emodin on the expression of proliferation cell nuclear antigen (PCNA): Cyclin during the mesangial cell cycle. J Cell Biol 15:174-176, 1993
38. LIU ZH, LI LS, HU WX, ZHOU H: The effect of emodin on the expression of c-myc mRNA and PCNA in the cell line SV-40. J Am Soc Nephrol 4:492, 1993
39. HU WX, LI LS, YAO J: Rheum officinale inhibited the production of interleukin 1 and tumor necrosis factor by macrophages. Bull Jinling Hosp 4:404-407, 1991
40. LIU ZH, LI LS, HU WX, ZHOU H: Effect of IL-6 on c-myc protooncogene expression in human mesangial cells and the down regulation by Emodin. J Nephrol Dial Transplant 2:58-61, 1993
41. YANG JW, LI LS, HU WX: Effect of rheum on compensatory renal growth in the rats. Bull Jinling Hosp 4:401-403, 1991
42. YANG JW, LI LS: Experimental study of rheum officinale on prevention of chronic renal failure. Chin J Nephrol 9:65-68, 1993
43. KLANE WF: Nephrology Forum: Lipids and the kidney. Kidney Int 46:910-920, 1994
44. ZHANG JH, LI LS, YU YS, WANG QW: Chronic renal failure with various underlying diseases-clinical features and the responses to rheum officinale. J Nephrol Dial Transplant 2:66-70, 1993
45. ZHANG JH, LI LS, WANG BZ: Effect of rhubarb on lipid abnormalities in chronic renal failure. Chin J Nephrol 9:133-135, 1993
46. ZHANG JH, YAO XD, SONG Y, YU YS, TANG Z, WANG QW: The long-term effects of rhubarb on preventing progression of chronic renal failure. Chin J Nephrol 9:197-201, 1993
47. ZHANG JH, LI LS, ZHANG M: Clinical etfects of rheum and captopril on preventing progression of chronic renal failure. Chin Med J 103:788-793, 1990
48. CAMERON JS: The future of nephrology with special regard to advances in treatment. Kidney Int (suppl 38) 42:S203-S214, 1994
49. KLAHR S: Low-protein diets and angiotensin-converting enzyme inhibition in progressive renal failure. Am J Kidney Dis 22:114-119, 1993
50. DIRKS JH, BRENNER BM: Mechanisms of injury in progressive renal diseases: Insights from experimental data summary and concluding remarks. Kidney Int (suppl 45):S22-S23, 1994
51. ZATZ R, FUJIHARA CK: Glomerular hypertrophy and progressive glomerulopathy. Is there a definite pathogenetic correlation? Kidney Int (suppl 45): S27-S29, 1994
52. SCHRIER RW, SHAPIRO JI, CHAN L, HARRIS DCH: Increased nephron oxygen consumption: potential role in progression of chronic renal disease. Am J Kidney Dis 23:176-182, 1994
53. SHAPIRO JI, ELKINS N, REISS OK, SULEYMANLAR G, JIN H, SCHRIER RW, CHAN L: Energy metabolism following reduction of renal mass. Kidney Int (suppl 45):S100-S105, 1994
54. BECKER GJ, WHITWORTH GA, IHLE BU, SHAHINFAR S, KINCAID-SMITH PS: Prevention of progression in non-diabetic chronic renal failure. Kidney Int (suppl 45):S167-S170, 1994
55. STRIKER G: Report on a workshop to develop management recommendations for the prevention of progression in chronic renal disease. J Am Soc Nephrol 5:1537-1540, 1995
56. ZUCCHELLI P, ZUCCALA A, BORGHI M, FUSAROLI M, SASDELLI M, STALLONE C, SANNA G, GAGGI R: Long-term comparison between captopril and nifedipine in the progression of renal insufficiency. Kidney Int 42:452-458, 1992
57. HEEG JE, DE: JONG PE, VAN DER HEM GK, DE ZEEON D: Reduction of proteinuria by angiotension converting enzyme inhibition. Kidney Int 32:78-83, 1987
58. ANDERSON S, RENNKE HG, BRENNER BM: Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat. J Clin Invest 77:1993-2000, 1986
59. GRIFFIN K, BIDANI A, PICKEN M: The glomeruloprotective efficacy of antihypertensive agents in the rat remnant kidney model: Correlation with continuously monitored BP (abstract). J Am Soc Nephrol 3:739, 1992
60. KAMPER AL, STRANDGAARD S, LEYSSAC PP: Effect of enalapril on the progression of chronic renal failure. A randomized controlled trial. Am J Hypertens 5:423-430, 1992
61. YANG JW, LI LS: Effects of rheum officinale on the renal hypertrophy and hyperfiltration in the streptozotocin-induced diabetic rat. Chin J Integr West Med 1:131-137, 1993
62. CONGER JD, FALK SA, GILLUM DM: The protective mechanism of thryoidectomy in a rat model of chronic renal failure. Am J Kidney Dis 13:217-225, 1989
63. HENDRICKSE RG: Epidemiology and prevention of kidney disease in Africa. Symposium on renal disease in the tropics. Trans R Soc Trop Med Hyg 74:8-16, 1980
64. LI LS, LIU ZH, TAO K, NICHOLLS K, KINCAID-SMITH P: IgA nephropathy in Chinese and Australian patients: a comparison between clinical and pathological features. Natl Med J China 71:153-155, 1991
65. LIU ZH, LI LS: Significance of glomerular IgM deposition and primary IgA nephropathy - An analysis of repeat renal biopsy in 40 cases. Natl Med J China 70:324-326, 1990
66. JIANG GW, CHEN XM, LI LS: Inhibition of the proliferation of mesangial cell by Rhubarb. Chin J Nephrol 6:133, 1990
67. RHUBARB COOPERATIVE STUDY GROUP, SHANGHAI: Toxicology of rhubarb. Information on Metallorgical Medicine 7:97, 1990.
68. LAI KN, LAI FM, CHAN KW, CHOW CB, TONG KL, VALLANCE-OWEN J: The clinicopathological features of hepatitis B virus associated glomerulonephritis. Q J Mad 63:323-333, 1987
69. LEE HS, CHOI Y, YU SH, KOH HI, KIM MJ, KO KW: A renal biopsy study of hepatitis B virus associated nephropathy in Korea. Kidney Int 34:537-543, 1988
70. JOHNSON RJ, COUSER WG: Hepatitis B infection and renal disease: clinical, immunopathogenetic and therapeutic consideration. Kidney Int 37:663-679, 1990
71. ZHANG JH, LI LS: Hepatitis B virus infection and glomerulonephritis, in Nephrology Proceedings of the 4th Asian-Pacific Congress of Nephrology (1st ed), edited by ZHANG JH, DU XH, LIU ZH, LI HS, International Academic Publishers, Beijing, 1991, p 338
72. LAI KL: Hepatitis B virus associated glomerulonephritis, in Nephrology Proceedings of the 4th Asian-Pacific Congress of Nephrology (1st ed), edited by ZHANG JH, DU XH, LIU ZH, LI LS, International Academic Publishers, Beijing, 1991, p 347
73. TAKEKOSHI Y, TOCHIMARU H, NAGATA Y, ITAMI N: Immunopathogenetic mechanisms of hepatitis B virus-related glomerulopathy. Kidney Int 40 (suppl 25):S34-S39, 1991
74. IIDA H, IZUMINO K, DIENSTAG JL, COLVIN RB, HAUPERT GT JR, MUSHAHWAR IK, MCCLOSKEY RT: Hepatitis B immune complex glomerulonephritis: IgA nephropathy unrelated to hepatitis B surface antigenemia. Nephron 42:335-339, 1986
75. TER WEE PM, DONKER AJM: Renal reserve filtration capacity: can it predict progression of chronic renal failure? Am J Kidney Dis 152(suppl I):71-75, 1991
76. YANG JW, LIU ZH, ZHOU H, ZHANG JH: Rheum officinale down-regulation gene expression of growth factors in glomeruli from diabetic rats. Chin J Nephrol Dial Transplant 3:255-258, 1994
77. CHEN QIONG-HUA, ZHAO YONG-QUI, LIN DIAN-DONG: Inhibition of tumor cells DNA synthesis by emodin and rhein in vivo and in vitro. Acta Pharm Sinica 3:363-367, 1966
78. + antiporter (NHE-1 isoform) in cultured vascular smooth muscle cell from the spontaneously hypertensive rat. Kidney Int 47:78-87, 1995
79. 2+) and pH (abstract). J Am Soc Nephrol 3:515, 1992
80. LI LEI-SHI, ZHENG FENG: Effect of Emodin on ATP metabolism of renal proximal tubular cells. Chin J Integrated Traditional and Western Medicine (special issue) 13:240-244, 1993
81. TAO S, WU X, LIU G, LIN L: Advice in checkup of Chinese popular hypertension and preventive medication program. Chin J Hypertens 2:1-3, 1994